Europe’s caution over Oxford vaccine about more than the science
Analysis: the evidence for side-effects is scant but governments have other factors to consider
As France and Germany join Ireland, Norway, Denmark and the Netherlands in suspending the use of the Oxford/AstraZeneca vaccine - even though the European Medicines Agency and the World Health Organization are advising people to continue taking it - the common refrain in European governments is that they are acting out of an abundance of caution".
There have been a handful of reports of blood clots in people recently vaccinated and also a rarer condition called thrombocytopenia, in which people do not make enough platelets. That can result in excessive bleeding. Deaths have been reported in Austria and Italy, which stopped the use of one batch of vaccine for fear it was contaminated. Meanwhile a further death from thrombocytopenia has been reported in Norway, as well as three hospitalisations.
Continue reading...